SUBLIMED actiTENS Gebrauchsanleitung Seite 244

België / Belgique / Belgien / Belgium
FAMHP- Federal Agency for Medicines and Health Products
Place Victor Horta 40, box 40, B - 1060, Brussels
E-mail : meddev@afmps.be
Deutschland / Germany
Federal Institute for Drugs and Medical Devices
Kurt Georg Kiesinger Allee 3, D - 53175 Bonn,
fax : +49 228 207 5300
E-mail : medizinprodukte@bfarm.de
France
Agence nationale de sécurité du médicament et des
produits de santé (ANSM)
143-147 boulevard Anatole France,
FR - 93285 Saint Denis Cedex
E-mails exclusively for correspondence between authorities
: medicaldevicesvigilance@ansm.sante.fr
Other purposes : materiovigilance@ansm.sante.fr
Ireland / Eire
Health Products Regulatory Authority
Kevin O'Malley House, Earlsfort Centre,
Earlsfort Terrace, IE - Dublin 2
E-mail : devicesafety@hpra.ie
Italia / Italy
Ministry of Health, Directorate General of Medical Devices
and Pharmaceutical Services
Via Giorgio Ribotta 5, IT - 00144 Roma, Vigilance on
Medical DevicesHead of Unit 5
E-mail : dgfdm@postacert.sanita.it, vigilance@sanita.it,
l.lispi@sanita.itMDD
244
137, rue de Mayoussard
38430 Moirans
France
+33(0)4 76 37 17 58
contact@subli-med.com
www.subli-med.com
actiTENS
2797
Premier marquage obtenu en janvier 2018
Liechtenstein
Office of Public Health
Äulestrasse 51, Postfach 684, FL - 9490 Vaduz
E-mail : medical.devices@llv.li
E-mail: medizinprodukte@basg.gv.at
Luxembourg
Ministère de la Santé, Direction de la Santé
tél : +352 247 85612 Villa Louvigny - allée Marconi,
L - 2120 Luxembourg
E-mail : meddevices.vigilance@ms.etat.lu
Nederland / Netherlands
Dutch Health and Youth Care Inspectorate,
IGJ Information Office (Meldpunt)
Stadsplateau 1 | 3521 AZ | Utrecht,
postal address : Postbus 2518 | 6401 DA | Heerlen
E-mail : meldpunt@igj.nl
Österreich / Austria
(BASG) Bundesamt für Sicherheit im Gesundheitswesen
Traisengasse 5, A-1200 Vienna,
E-mail : medizinprodukte@basg.gv.at
Suisse
Swissmedic, Swiss Agency for Therapeutic
ProductsMedical Devices Division
Hallerstrasse 7, 3012 Bern, Switzerland
E-mail : materiovigilance@swissmedic.ch
SBM1AL001
SBM1AL001 – Notice_202105_v8